OCI-5/Glypican 3, a member of the glypican family of proteoglycans, is the defective gene in the SimpsonGolabi-Behmel overgrowth syndrome. OCI-5 expression is developmentally regulated in the intestinal epithelium, and the mechanism of its regulation was studied in the rat intestinal epithelial cell line IEC-18. A large induction of OCI-5 transcript and protein was observed at high cell density. Among other glypican family members, k-glypican also exhibited a con¯uence-dependent induction in select cell types. Nuclear run-on analysis indicated that cell-density regulation of OCI-5 occurs at the level of transcription. The rat and mouse OCI-5 promoters were cloned and found to be highly conserved, located within CpG islands and contain regions of alternating purine and pyrimidine residues. No TATA-box or recognizable INR element was observed. Consensus binding sites for AP-2, SP-1, zeste and NF-1/CTF are conserved across human, mouse and rat promoters. 5' deletion mapping of the rat promoter identi®ed regions which enhance and repress promoter activity, with no apparent con¯uence-dependence or tissue-speci®city. Nuclear run-on analysis probing dierent regions of the gene suggests that elongation control plays a role in the induction of OCI-5 by con¯uence.
Introduction
On a molecular level, morphogenesis of the intestinal epithelium during development is poorly understood. Few genes whose products are involved in these processes have been identi®ed and still less is known about the regulation of expression of such genes. OCI-5, a member of the glypican family of integral membrane proteoglycans (David, 1993) , was originally isolated from the primitive rat intestinal epithelial cell line IEC-18 (Filmus et al., 1988) . By virtue of its expression characteristics, OCI-5 is believed to be involved in morphogenesis during the development of several tissues including the intestine. Recently, Pilia et al., have identi®ed the human homologue of OCI-5, which they termed glypican-3 (GPC3), as the causative gene in the Simpson-Golabi-Behmel overgrowth syndrome (SGBS) . SGBS is an Xlinked disorder characterized by gigantism, multiple congenital malformations, and a predisposition for childhood tumors such as Wilms' tumor and neuroblastoma (Golabi and Rosen, 1984; Hughes-Benzie et al., 1992; Terespolsky et al., 1995) . GPC3 is a large gene, spanning over 500 kb with a minimum of 8 exons. Various deletions and translocations have been identi®ed within introns 2 and 7, and across most exons of the gene Lindsay et al., 1997; Pilia et al., 1996) . The identi®cation of GPC3 as the SGBS gene is strong evidence for a role of OCI-5 in growth regulation and morphogenesis. Previous studies with other membrane-bound heparan sulphate proteoglycans suggest that the basis for a role of OCI-5 in these processes is the ability to interact with growth factors and extracellular matrix proteins (David, 1993; Hardingham and Fosang, 1992; Ruoslahti, 1989) .
OCI-5/GPC3 sequences are very well conserved through evolution, the rat protein having a 92% identity to the human (GenBank # U50410). Although the mouse OCI-5 has been sequenced only partially, over the available 241 residues combined from Watanabe et al. (1995) and the mouse genomic DNA clone described in this paper, there is a 99% sequence identity to the rat protein. In fact, all members of the glypican family are highly conserved across species and more loosely related to each other, having in common a similarity in size, attachment to the cell membrane through glycosyl-phosphatidylinositol (GPI) anchoring, 14 cysteine residues at conserved positions and potential glycosaminoglycan attachment sites. To date, this family consists of ®ve members in mammalian cells, including OCI-5/GPC3 (Filmus et al., 1995) , glypican/GPC1 (David et al., 1990) , cerebroglycan/GPC2 k-glypican/ GPC4 (Watanabe et al., 1995) and the most recently identi®ed GPC5 (Veugelers et al., 1997) . In Drosophila, a gene highly homologous to glypicans has been identi®ed. This gene, called dally, has also been implicated in growth control during development (Nakato et al., 1995) . The dally protein is required for normal cell division during development of the nervous system and mutations aecting dally expression also result in developmental abnormalities in multiple other organs, including the eye, antenna, wing and genitalia.
In the embryo, the OCI-5 transcript is highly expressed in the region of the jaw and tongue, oesophagus, intestine, aorta, trachea, lung, liver, kidney and developing bone (unpublished observations). The expression of OCI-5 during intestinal development in the rat is temporally and spatially regulated (Li et al., 1997) . The OCI-5 transcript can be detected both in endoderm-and mesenchyme-derived cells in a phased manner related to age and proximaldistal position. The levels of expression correlate with the wave of morphogenesis moving from duodenum to colon during the last 5 days of gestation. Once morphogenesis is complete the OCI-5 transcript is down-regulated, becoming undetectable after weaning (Filmus et al., 1988) .
These expression patterns of OCI-5 suggest that knowledge of the mechanism regulating OCI-5 expression will contribute to our understanding of transcriptional regulation during intestinal development and morphogenesis. This report describes several aspects of the regulation of OCI-5 expression in IEC-18 cells, including identi®cation of a con¯uence-dependent upregulation, cloning and analysis of the rat and mouse promoter regions, and characterization of a transcriptional pausing mechanism that seems to be involved in the regulation of OCI-5 expression with con¯uence.
Results

OCI-5 is induced with con¯uence
The expression of OCI-5 transcript was analysed in IEC-18 cells as they approach con¯uence. As seen in Figure 1a , the OCI-5 transcript is dramatically induced in con¯uent IEC-18 cells and remains elevated for several days post-con¯uence. These cells are stable as a contact-inhibited monolayer in the post-con¯uent state if the cells are regularly supplied with fresh medium. The induction of OCI-5 is gene-speci®c as demonstrated by probing the same Northern blot with a tubulin cDNA. Tubulin transcripts show no variation with con¯uence and correlate with the intensity of the ribosomal bands (not shown), con®rming equal loading in all lanes. Similar results are obtained with the probes GAPDH and ribosomal L32 (see Figures 1b, 2, 3 ) and when RNA loading is normalized by analysing equal cell-equivalents per lane (data not shown).
The con¯uence-dependent induction of OCI-5 is not unique to IEC-18 since a similar induction with con¯uence is seen in other OCI-5 expressing cell lines, including other cells of the IEC series ± IEC-17 and IEC-20, CaCo-2 colon carcinoma, RFL-6 fetal lung, and the DB lung tumor cell line (Figure 1b) . The increase in OCI-5 with con¯uence is also seen at the protein level (Figure 1c) . Western blotting of cell extracts from IEC-18 cells shows an increase in the intensity of bands corresponding to the core protein of 65 and 45 kDA) in con¯uent cells, relative to sub-con¯uent cells. The 65 and 45 kDa bands are believed to represent proteolytic cleavage products of the full length core protein (70 kDa) and similar bands are also seen in Cos-1 cells transfected with an OCI-5 cDNA, but not in mock transfected Cos-1 cells (Filmus et al., 1995) and not in the IEC-14 intestinal epithelial cells which do not expresss OCI-5 transcript (not shown). The intense band around 60 kDA is a nonspeci®c species recognized by the polyclonal antibody and serves to con®rm equal loading in the lanes.
To determine whether induction by con¯uence is a common feature of glypican family members, Northern blot analysis for k-glypican and glypican was performed in multiple cell lines. As seen in Figure 2 , expression of glypican can be detected in cell lines from dierent origins including epithelial cells (IEC and NRK-52E cells), endothelial cells (tEnd) and fibroblasts (Rat I and Rat II), consistent with the relatively wide tissue distribution previously observed for glypican (Lories et al., 1992) . However, glypican transcript levels do not appear to vary between subcon¯uent and con¯uent cells in any case. In contrast, k-glypican, originally identi®ed as being highly expressed in developing brain and kidney, is induced with con¯uence in the NRK-52E, Rat I and Rat II cell lines. Expression of k-glypican is detectable in IEC cells, but not regulated by con¯uence. Thus, con¯uence-dependent induction is not unique to OCI-5, but is another attribute with a tissue-speci®c distribution amongst glypican family members.
OCI-5 expression is regulated at the level of transcription
The mechanism of OCI-5 induction in con¯uent IEC-18 cells was analysed using nuclear run-on analysis. Shown in Figure 3 is the activation of OCI-5 transcription as IEC-18 cells progress from 25% con¯uence to 2 days post-con¯uence (+2). Although double-stranded cDNA probes were used in this analysis, the presence of an antisense transcript was considered unlikely since no bands are seen on Northern blots probed with an in vitro transcribed sense OCI-5 probe (not shown). Additionally, no OCI-5 speci®c signal is detectable in nuclear runons performed with IEC-18 nuclei less than 50% con¯uent or nuclei from multiple cell lines which do not express OCI-5, indicative of the absence of an antisense transcript. In this experiment there was roughly a 33-fold increase in the steady state levels of OCI-5 between 25% con¯uence and post-con¯uence as assessed by Northern blotting (Figure 3a) . The magnitude of this induction could not be veri®ed in nuclear run-on experiments due to detectability limits of OCI-5 transcription in sub-con¯uent nuclei. However, the 5.5-fold increase in steady-state levels of OCI-5 mRNA seen when 50% con¯uence is compared to postcon¯uence correlates well with the sixfold induction of OCI-5 speci®c transcription in nuclei prepared from the same cells (Figure 3b ). In six repetitions of the experiment, transcriptional activation accounted for 98% (s.d.=18%) of the steady-state induction. Thus, con¯uence-dependent expression of OCI-5 is regulated at the level of transcription.
Sequence analysis of the rat and mouse promoter regions
Screening of rat and mouse genomic DNA libraries resulted in the isolation of OCI-5 genomic clones spanning sequences 5' to exon 1, and part of intron 1. Numbered relative to the transcription initiation site as determined below, approximately 6.1 and 0.9 kb of 5' anking DNA was isolated for the rat and mouse OCI-5, respectively. A restriction map of the largest rat genomic clone, Epr5, is shown in Figure 4 . Epr5 contains 10.8 kb of genomic DNA including 6.1 kb of 5'-¯anking DNA, exon 1, and approximately 4.4 kb of the ®rst intron. A 5.4 kb EcoR1 restriction fragment of Epr5 hybridizing to the N-terminus of OCI-5 was subcloned into PUC18 and designated pE5. A detailed restriction map of pE5 was generated and the beginning of the OCI-5 cDNA was localized and oriented to a 131 bp Aval restriction fragment by hybridization (Figure 4) . Sequencing of pE5 downstream into the OCI-5 gene, a 100% identity was found to the corresponding sequences in the OCI-5 cDNA, confirming the authenticity of the genomic clone. At nucleotide 286 of the OCI-5 cDNA, the two sequences diverge and a perfect 5' splice site consensus sequence is found in the genomic clone.
The rat promoter region was sequenced to 71443 (GenBank # U62019), and the mouse to 7932 (GenBank # U76712). Alignment of the rat and mouse promoters reveals a striking degree of conservation between them, exhibiting almost a 93% identity over the regions shown in Figure 5 . Comparison of 1.1 kb of the rat promoter to the corresponding region in the human GPC3 gene (GenBank # L47124) reveals a 76% identity. Examination of the OCI-5 promoter sequences reveals several interesting features. First, the sequence within 250 bp upstream of the gene has a high G+C content (72%) in both rat and mouse. This, together with the presence of multiple GC boxes (GGGCGG) and restriction sites for the enzymes SmaI and MspI, is diagnostic of a CpG island (Bird, 1989; Gardiner-Garden and Frommer, 1987) . The upstream region of the human GPC3 gene has also been shown to
Figure 2 Northern probing of IEC-18 RNA from 25% con¯uence to 2 days post-con¯uence (+2). Data are obtained from phosphorimager ®les and OCI-5 levels are normalized to GAPDH (OCI-5/ GAPDH). (b) Nuclei were isolated from the same cells used in part (a) for nuclear run-on analysis. Counts for the puc18 signal were subtracted from OCI-5 and GAPDH cDNA probes before normalization (OCI-5/GAPDH). Levels of OCI-5 transcription in 25% con¯uent cells is not distinguishable from the background puc18 signal lie within a CpG island . Second, in all species, the OCI-5 promoter region does not contain a TATA box consensus sequence. Nor is there a match to any known initiator (INR) elements (Weis and Reinberg, 1992) , although the consensus for these elements is more poorly de®ned. Third, regions of alternating purine and pyrimidine (APP) bases are found within both the rat and mouse promoters. In the rat, the APP region is located between 7759 and 7857 and consists of d(A-T) 22 immediately followed by d(G-T) 27 . APP regions in the mouse promoter include a d(C-A) 22 stretch from 7865 to 7908, and d(G-T) 21 located at 7522 to 7563. A computerized search through the NCBI transcription factor database identi®es consensus binding sites for several transcription factors in both the rat and mouse promoters. These are underscored with the name of the transcription factor printed above in Figure 5 , and include potential binding sites for the transcription factors SP-1 (Kadonaga et al., 1987) , AP-2 (Imagawa et al., 1987; Mitchell et al., 1987) , bicoid (Hanes and Brent, 1991) , zeste (Biggin and Tjian, 1989) , AP-1 (Lee et al., 1987) , and NF-1/CTF (Santoro et al., 1988) . A similar analysis of the GPC3 5'¯anking region identi®es three elements which are conserved across human, rat and mouse promoters. These include the AP-2 and overlapping AP-2/SP-1 sites beginning at 720, a zeste site beginning at 7280, and a potential NF-1/CTF binding site starting at 7362.
OCI-5 has a single, major transcription start site
Both primer extension and S1 nuclease mapping indicate that the OCI-5 gene has a single, major transcription start site (Figure 6b and c) . The size of the major primer extension product (173 bp) from IEC-18 RNA indicates the OCI-5 cDNA originally cloned is missing 32 nucleotides from its 5' end, and the length of the S1 nuclease protected probe (87 bp) is consistent with this RNA start site. No larger bands were consistently observed. A smaller band, four nucleotides downstream, is protected from S1 nuclease digestion and a corresponding band can be seen in the primer extension, but this band is signi®cantly weaker. Other smaller bands seen in the primer extension are likely due to stalling of the reverse transcriptase since corresponding fragments were not protected in the S1 nuclease mapping. Identical results are obtained when comparing primer extension from CaCo-2 and IEC-18 RNA, indicating that the human and rat genes have the same initiation site (Figure 6d ). In conjunction with the splice donor site located at nucleotide 286 of the OCI-5 cDNA, the ®rst exon of OCI-5 is therefore determined to be 318 base pairs long.
To con®rm the results obtained by S1 nuclease mapping and primer extension, 5' RACE cloning was performed from both CaCo-2 and IEC-18. The largest clones, independently isolated twice from CaCo-2 and three times from IEC-18, extend the reported cDNA sequence by exactly 32 nucleotides (data not shown). Several smaller clones ending within ten nucleotides of the full-length transcript were also observed. The sequence of the full-length RACE clones from IEC-18 was 100% identical to the corresponding region in pE5; and the sequence from the CaCo-2 clones was identical to the beginning of the cDNA sequence of GPC3 (GenBank # L47124).
Deletion mapping of the OCI-5 promoter
To analyse promoter activity, the rat OCI-5 promoter region from 71410 to +49 was cloned into the pGL3-basic luciferase reporter vector (p1410) and sequential 5' deletions from this plasmid were made using convenient restriction enzymes. Plasmids p549, p199 and p46 are named according to the amount of upstream DNA they contain, relative to the transcription initiation site. Transient transfection of these plasmids into IEC-18 reveals that relative to the p1410 construct, deletion to 7549, which includes the APP region, decreases luciferase activity by 57% (Figure 7) . Further deletion to 7199 increases activity 5.3-fold, relative to p549. This region encompasses the conserved binding sites for the NF-1/CTF and zeste transcription factors. Deletion of a series of AP-2 and Sp-1 sites clustered between 7199 and 746 results in a fourfold reduction in promoter activity. Finally, the p46 construct has deleted all but the ®rst set of conserved AP-2/SP-1 binding sites and still retains promoter activity approximately 76 greater than the promoter-less pGL3 basic.
Transfection of the reporter constructs into IEC-18 cells at various con¯uence states failed to identify a promoter region which was sensitive to con¯uence eects. Similarly, elements which direct tissue-speci®c expression of OCI-5 do not appear to be located within the 1.4 kb of rat promoter sequence. The results of transfecting the same promoter constructs into NRK-52E cells, in which OCI-5 expression cannot be detected by Northern probing, is also seen in Figure 4 Restriction map of rat OCI-5 genomic DNA clone. Restriction maps of genomic clone Epr5 and its EcoRI subclone pE5. Direction of transcription unit is indicated by the arrow. Open box depicts the ®rst exon, black box the ®rst intron and the AvaI fragment used in S1 nuclease analysis is indicated in hatching. *FspI sites used for generating promoter constructs. Distances given in kb (Epr5) or bp (pE5), not drawn to scale. Restriction sites are shown for SalI (Sa), EcoRI (RI), SStI (Sst), FspI (F), KpnI (K), XbaI (xb), BanII (B), PstI (P), XmnI (xm), HindIII (H), AvaI (Av), SmaI (Sm) and SspI (Ssp) Figure 7 . These results show that OCI-5 promoter activity in NRK-52E cells is similar to IEC-18 cells, with the exception of the p549 construct. In contrast to IEC-18 cells, deletion of a region containing the APP element does not appear to reduce promoter activity in NRK-52E.
Lack of tissue-speci®c expression by the 71410 to +49 region of the rat OCI-5 promoter was also seen using the pXpl luciferase reporter vector (Nordeen, 1988) and was demonstrated in other OCI-5 nonexpressing cell lines, including the IEC-14 intestinal epithelial cell line, HT-29 colon carcinoma, and AuxB1 Chinese hamster ovary cells (data not shown). 5' RACE cloning of luciferase transcripts from transiently transfected cells con®rms that transcription is initiating within the OCI-5 promoter, and nuclear runon analysis performed with NRK-52E, HT-29 and AuxB1 cells rules out the possibility that these cells are actively transcribing an unstable OCI-5 transcript (not shown). In addition to initiation, transcriptional elongation has been shown to be a rate-limiting step in gene regulation (Bentley, 1995; Krumm et al., 1995) and certain secondary structures can aect elongation of transcription in several genes (Bengal and Aloni, 1991; Krumm et al., 1992) . The STEMLOOP program in the GCG sequence analysis package identi®es a strong potential stem-loop structure from position +6 to +27 of the OCI-5 transcript. In addition, human and rat cDNAs isolated in this laboratory had identical 5' ends, both terminating at position +32. Moreover, inhibition of transcription by actinomycin D, as well as translational repression by cyclohexamide, causes an initial induction of OCI-5 before transcript levels begin to decline (unpublished observations). These ®nding, together with the rapid induction of OCI-5 at con¯uence, and the lack of tissue-speci®city and con¯uence-dependence of its promoter, suggested that a short-lived repressor may regulate OCI-5 expression by aecting polymerase read-through at a region of high secondary structure in the beginning of the OCI-5 transcript. As an initial attempt to address this hypothesis, nuclear run-on analysis was performed using probes which span the full length of the OCI-5 transcript.
In these assays, transcriptionally engaged polymerase complexes continue to elongate for an average of 100 to 200 nucleotides, and the nascent radiolabelled RNA is alkali lysed to further reduce the size of the hybridizing species before annealing to probes spanning dierent regions of the gene. Thus, these nuclear run-ons measure the distribution of polymerase complexes within a gene at the time of nuclear isolation. A`block' to transcription elongation is de®ned as an excess of engaged RNA polymerase II complexes in a 5' region of the gene, compared to a 3' region.
Shown in Figure 8a are the locations of the probes used in the nuclear run-on analysis. Probe A encompasses the transcription initiation site and lies within the ®rst exon, while probe B is from exon 2. Below are typical results from a nuclear run-on reaction using 50% con¯uent and 2 days postcon¯uent nuclei. In order to obtain quanti®able signals, twice as many nuclei were used for subcon¯uent as compared to con¯uent samples, as re¯ected in the intensity of the GAPDH signals.
The results of nuclear run-on analysis using probes A through E are graphed in Figure 8b , where phosphorimaging data for each of the probes is plotted for sub-and post-con¯uent cells. Data are represented with the background signal from a puc18 control subtracted before normalizing for probe UTP content and further correction for the number of nuclei used in the experiment (counts/6610 7 nuclei). Similar results are obtained with data normalized to either GAPDH or L32 probes. is shown with AvaI sites used for S1 nuclease mapping, location of primer 5RT used in primer extension, the start of translation (ATG) and the resulting transcription initiation site (+1) indicated. (b) Primer extension reactions were performed with primer 5RT using IEC-18 (1) or NRK-52E (2) mRNA. (c) S1 nuclease mapping. Radiolabeled AvaI fragment (131 bp) was annealed to IEC-18 (3) or NRK-52E mRNA (4) before S1 nuclease treatment. A DNA sequence ladder generated by sequencing of the OCI-5 genomic clone with 5RT is used in both experiments to size the products. (d) Primer extension from IEC-18 and CaCo-2 mRNA using 5RT. Radiolabeled MspI digested puc18 is used as a size marker Figure 7 Deletion mapping of the rat OCI-5 promoter. Deletion constructs of the rat OCI-5 promoter region driving a luciferase reporter gene were transiently transfected into IEC-18 and NRK-52E along with a CMV-bgal plasmid by electroporation. Luciferase activity, normalized to b-galactosidase levels, are expressed relative to the largest construct, p1410. These results represent the mean and standard error of three to ®ve independent assays
In subcon¯uent cells, probe A has a signal approximately three times greater than probes B through E, i.e. the density of polymerase molecules is highest within probe A. In contrast, polymerase is more equally loaded across the probes in con¯uent cells, although as elongation proceeds, 3' most fragments are underrepresented due to the slowing of transcription (Rougvie and Lis, 1988) . The 3' most sequence downstream of probe E was found to exhibit poor hybridization eciency, as demonstrated by annealing to radiolabelled in vitro transcribed RNA, and was therefore not included in this assay.
A threefold block to transcription elongation is less than the relative eightfold induction in OCI-5 expression seen in the cells these studies were performed with (Figure 8c) . However, signals from probes B through D in con¯uent cells are approximately eightfold greater than in subcon¯uent cells, consistent with the induction seen in the Northern blot. Furthermore, the signal intensity from probe A in subcon¯uent cells is 2 ± 3-fold lower than in con¯uent cells, suggesting that new transcription initiation also occurs at con¯uence. Thus, the induction in OCI-5 expression seen at con¯uence is mediated by a combination of initiation and release of a block to transcription elongation, with the two mechanisms accounting for roughly 70% and 30% of the total induction, respectively.
Discussion
In this study, OCI-5 transcript and protein levels have been shown to be induced by cellular con¯uence in IEC-18 cells. This induction was shown not to be unique to IEC-18, but was also observed in other OCI-5 expressing cell lines including, IEC-17, IEC-20, RFL-6, DB and CaCo-2. Con¯uence-dependent gene regulation is not without precedence and a growing number of such genes are being identi®ed, many being involved with growth control or contact-dependent growth inhibition. Examples include IGFBP-3 (Blat et al., 1994) , bFGF and aFGF Kitaoka et al., 1993) , EGFR (Hamburger et al., 1991) , c-myc (Kumatori et al., 1991) , DEP-1 (Ostman et al., 1994) , and il-TMP (Wice and Gordon, 1995) . Con¯uence-dependent induction of the rat ®bronectin gene has recently been shown to be conferred by elements within 318 bp of its promoter (Perkinson et al., 1996) .
The con¯uence-dependent induction of OCI-5 in IEC-18 cells was previously analysed on a cellular level and shown to be a function of the change from a¯at, elongated morphology to the more rounded, compact cell shape associated with high cell densities (Li et al., 1997) . A role for cell shape in regulating developmental gene expression is increasingly recognized (Ingber, 1993; Ingber et al., 1994) and is likely to be found in genes which are expressed during tissue morphogenesis. It has also been shown here that k-glypican, another developmentally regulated member of the glypican family, is induced with con¯uence in select cell types. The induction of k-glypican with con¯uence was observed in kidney epithelial cells and ®broblasts, but not intestinal epithelial cells. k-glypican was originally isolated from mouse kidney and is highly expressed in fetal kidney and brain. Whether it is the cell shape change associated with con¯uence which mediates the induction of k-glypican remains to be determined, but these ®ndings suggest that cell shape regulation of developmental gene expression occurs in selective genes in a tissue-speci®c manner.
Investigation of the con¯uence-dependent induction of OCI-5 was extended by a molecular analysis of the mechanism mediating this phenomenon in IEC-18 cells. Nuclear run-on analysis demonstrates that the increase in steady-state OCI-5 transcript level seen on a Northern blot is matched by an equivalent increase in the transcription rate of the gene. It is likely that the transcriptional regulation of genes which function during development would be complex since they must respond to both positional and temporal signals; this certainly appears to be true for the OCI-5 gene.
The mouse and rat OCI-5 promoters were cloned and found to have several noteworthy features. In addition to the extremely high (93%) conservation between the mouse and rat sequences, these promoters fall into the emerging class of promoters lacking a TATA box (Azizkhan et al., 1993) . The OCI-5 promoter is unusual in that while most TATA-less promoters exhibit multiple transcription initiation sites, OCI-5 was shown to have a single, major transcription start site. Examples where this is the case are few, but include the TRH receptor (Iwasaki et al., 1996) and Fgfr3 (Perez-Castro et al., 1995) . It remains to be determined how a competent transcription complex is assembled in the absence of a TATA-box or a recognizable INR element. Deletion mapping of the rat OCI-5 promoter revealed that the region between 71410 and +49 does not regulate tissue-speci®c or con¯uence-dependent activity. However, analysis of this promoter region did identify regions critical for the basal transcription of OCI-5. A minimal promoter region was de®ned from 746 to +49. This region confers signi®cant promoter activity over that of pGL3 basic. While it is surprising that such a small region should retain promoter activity, a similar result is observed with the ®rst 47 nucleotides of the murine Cdx-1 promoter (Hu et al., 1993) . The ®rst 46 nucleotides of the OCI-5 promoter contains a set of overlapping AP-2 and SP-1 sites which are perfectly conserved between the human, rat and mouse promoters. A series of AP-2 and SP-1 binding sites are also removed between p199 and p46, resulting in decreased promoter activity. Clustered AP-2 and SP-1 binding sites have been found to regulate activity in multiple promoters (Oesterreich et al., 1996; Sato et al., 1995) . Deletion of the region between 7549 and 7199 resulted in an increase in reporter activity, suggesting deletion of a repressor element. This region encompasses potential NF-1/CTF and zeste binding sites which are conserved in the promoter sequences across species. Finer deletions and mutational studies will be required to assess the role of these elements in the regulation of OCI-5 expression.
The only promoter region which exhibited tissuespeci®c activity was between nucleotides 71410 and 7549. Deletion of these nucleotides decreases promoter activity in IEC-18, but not in NRK-52E cells. Within this region two AP-1 binding sites are found anking the APP element. APP sequences are capable of forming secondary structures in response to supercoiling (Nordheim and Rich, 1983) and this altered conformation has been shown to have regulatory eects on downstream transcription units (Krajewski, 1995; Wol¯et al., 1996; Yu and Edenberg, 1995) . d(G-T) n in particular has been shown to assume a lefthanded Z-DNA conformation under conditions of negative superhelical torsion (Banerjee and Grunberger, 1986). The twin-supercoiled-domain model of transcription suggests that APP regions located upstream of a transcribed gene adopt the Z-form in response to the negative supercoils generated in the wake of a moving RNA polymerase (Tsao et al., 1989) . Stretches of d(A-T) n have been shown to adopt cruciform structures and to inhibit the formation of Z-DNA in adjacent regions (Rajagopalan et al., 1990) . The juxtaposition of a d(A-T) n stretch adjacent to a d(G-T) n sequence,¯anked by AP-1 binding sites, in the rat OCI-5 promoter is intriguing in light of the fact that OCI-5 transcription is repressed in IEC-18 by Hras transformation (unpublished observations).
It is possible that regions located between 71410 and +49 may function in a tissue-speci®c or con¯uence-dependent manner by interacting with elements located elsewhere. The eects of further upstream DNA and sequences from within intron 1 are currently being investigated. Furthermore, the location of the OCI-5 promoter in a CpG island suggests that its methylation status could also have an impact on expression (Boyes and Bird, 1991) .
When OCI-5 was analysed at the level of transcription elongation, promoter-proximal pausing was observed upstream of +173 in subcon¯uent cells. This pausing was not observed in con¯uent cells, suggesting that con¯uence-dependent induction of OCI-5 is mediated in part by the release of an elongation block. When the OCI-5 cDNA was used as a probe (Figure 3b) , a low nuclear run-on signal was observed in subcon¯uent IEC-18 cells due to a combination of low transcription initiation, lack of elongation and the fact that the OCI-5 cDNA probe is missing 32 nucleotides relative to the short, nascent radiolabelled transcript. It may be that a pausing phenomenon accounts for the lack of steady-state OCI-5 transcript, despite activity of the OCI-5 promoter, in cell lines such as NRK-52E. Experiments are currently underway to substantiate this hypothesis.
It also remains to be determined whether the promoter-proximal pausing observed in subcon¯uent IEC-18 cells represents premature termination of transcription, with recruitment of a processive RNA polymerase II ternary complex at con¯uence, or the pausing of polymerase complexes capable of resuming elongation with con¯uence. Dierent transcription factors have been shown to have varying abilities to stimulate initiation, elongation, or both. For example, SP-1 is believed to stimulate non-processive transcription by increasing basal initiation; processivity being achieved in synergy with activators, such as HIV Tat, which speci®cally stimulate elongation (Kamine et al., 1993) . The abundance of potential SP-1 binding sites in the OCI-5 promoter suggests that such a mechanism may be operative in this case. Further analysis may allow for the identi®cation of an activator which stimulates processivity in the OCI-5 promoter.
The OCI-5 gene is the ®rst glypican family member to have its promoter cloned and characterized. Promoter mapping has identi®ed a minimal promoter and revealed that OCI-5 is regulated through the combined action of multiple positive and negative regulatory regions. This report contains an initial demonstration that both initiation and elongation regulate OCI-5 expression. The con¯uence-dependent induction of OCI-5 transcript was shown to be mediated by the release of an elongation block, a mechanism which is intuitively attractive in a gene whose expression is tightly regulated and rapidly induced during tissue morphogenesis.
Materials and methods
Cell culture
The IEC-17, IEC-18 and IEC-20 rat intestinal epithelial cell lines were grown in IEC media (a-MEM supplemented with 20 mM glucose, 2 mM glutamine, 0.27 units/ml insulin and 5% fetal bovine serum). For IEC-18, cells were routinely carried only up to passage 30, and con¯uence, as de®ned by the density at which cells cease to proliferate, was determined to be approximately 6610 6 cells/100 mm dish. All other cell lines were maintained in a a-MEM plus 10% fetal bovine serum, including CaCo-2 colon carcinomas, NRK-52E rat kidney cells, Rat-1 and Rat-II ®broblasts, RFL-6 fetal rat lung and DB human lung carcinoma. tEnd.1 mouse endothelial cells were obtained from Dr Yu Yamaguchi (La Jolla Cancer Research Foundation, La Jolla, California) and maintained in a-MEM plus 10% fetal bovine serun and 800 mg/ml G418.
Northern probing
Total RNA was extracted using TRIZOL reagent (Gibco, BRL). Electrophoresis was performed on 0.75% agaroseformaldehyde gels and transferred to Zetaprobe membranes (Bio-Rad Labs). Filters were probed with the OCI-5 cDNA (Filmus et al., 1988) , 4EX rat glypican cDNA , or pEco7a k-glypican cDNA (Watanabe et al., 1995) before exposure to a phosphorimager screen and quantitation with ImageQuant software (Molecular Dynamics). Normalizing genes used in Northern blots and nuclear run-on experiments included probes from tubulin (Elliott et al., 1985) ; GAPDH (Fort et al., 1985) and ribosomal protein L32 (Rajchel et al., 1988) .
Western blotting
Cell extracts were prepared by lysis at 08C for 30 min in RIPA buer (1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 2 mM PMSF, 10 mM EDTA and 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mg/ml pepstatin in PBS). 200 mg cell extract was run on a 4 to 9% SDSpolyacrylamide gradient gel. Proteins were transferred to a polyvinylidene di¯uoride membrane (Dupont), and standard Western blotting procedures were followed as described in the ECL Western Detection Kit (Amersham). Polyclonal antibody against OCI-5 was generated by injecting rabbits with a GST-fusion protein containing the last 70 amino acids of OCI-5.
Nuclear run-on analysis
Nuclear run-ons were performed as described previously (Hu et al., 1995) with some modi®cations. Probes used in these assays included gel puri®ed rat OCI-5 insert cDNA, or fragments spanning the length of the transcript (probes A through E). Probes C through E were isolated as gel puri®ed restriction fragments from the rat OCI-5 cDNA, while probe B was ampli®ed from the cDNA by PCR using gene-speci®c primers. Probe A was generated by gene-speci®c PCR from a 5' RACE clone of OCI-5 mRNA in IEC-18 cells, and thus encompasses the transcription initiation site. When hybridization was performed against fragments of cDNA, radiolabeled RNA was fragmented in 0.3 M NaOH for 10 min on ice before NH 4 Ac precipitation and hybridization to dot blots containing 0.5 mg of gel puri®ed DNA or puri®ed PCR products. Quantitation was performed using ImageQuant software following a 7 day exposure to a phosphorimager screen.
Genomic DNA library screening and sequencing
To isolate the rat promoter, an EcoRI-HgiAI restriction fragment encompassing the ®rst 91 bp of the N-terminus of the OCI-5 cDNA was used to screen a Bualo rat liver genomic DNA library (generously provided by Dr WP Fung- Leung (Fung and Schreiber, 1987) ). Three overlapping clones were isolated and the one containing the most upstream sequence identi®ed by restriction mapping, designated Epr5, was chosen for further characterization. Portions of Epr5 were subcloned and restriction mapped to localize the beginning of the cDNA and 1.5 kb of 5'-anking DNA was sequenced in both orientations using Sequenase version 2.0 (USB) through a combination of subcloning and primer walking as sequence information was generated.
The 5' region of the mouse OCI-5 promoter was isolated by screening a 129J mouse genomic DNA library (generously provided by Dr Tak W Mak). A 1.5 kb EcoRI fragment of the resulting genomic DNA clone encompassing 0.9 kb 5' anking DNA, exon 1 and 0.6 kb of intron 1 was subcloned and sequenced up to the beginning of intron 1.
Transcription initiation site mapping
The transcription initiation site was determined through a combination of primer extension, S1 nuclease mapping, and 5' RACE cloning. For primer extension, 2 mg of poly(A + ) RNA was annealed to 2.5610 4 c.p.m. of g 32 P-ATP labeled primer (5RT) complementary to nucleotides 110-141 of the OCI-5 cDNA in S1 buer (0.4 M NaCl, 40 mM PIPES pH 6.4, 0.5 mM EDTA) plus 50% formamide at 508C overnight. Primer was extended in 50 mM Tris pH 8.2, 8 mM MgCl 2 , 10 mM DTT, 0.5 mM dNTPs and 10 units AMV reverse transcriptase at 428C for 1 h. S1 nuclease mapping was performed with a 131 bp AvaI fragment from pE5 which encompasses the 5' end of the OCI-5 cDNA. 1.5610 6 c.p.m. of 5' end-labeled AvaI fragment was annealed to 4 mg poly(A + ) RNA in S1 buer plus 80% formamide overnight at 508C, followed by tenfold dilution with 0.28 M NaCl, 50 mM NaAc pH 4.5, 4.5 mM ZnSo 4 , 200 mg/ml denatured salmon sperm DNA and 400 units S1 nuclease (Boehringer Mannheim), and incubation at 428C for 1 h. Primer extension and S1 nuclease reactions were stopped and precipitated before running on a 6% polyacrylamide, 8 M urea gel along with a DNA sequence ladder generated by sequencing of the OCI-5 genomic clone with 5RT.
5' RACE cloning was performed as described in Frohman et al. (1988) . Primer extension was initiated with a primer complementary to nucleotides 567-584 of the OCI-5 cDNA, and an internal primer complementary to nucleotides 301-317 was used for PCR ampli®cation along with an EcoRI-dT 24 adapter. PCR products were run on a 2% agarose gel, transferred to Hybond-N membrane and hybridized with the 5RT primer. A positive band around 400 bp was isolated, digested with EcoRI and PstI (at position 248 in the cDNA) and subcloned into the EcoRI/PstI sites of puc18. Clones identi®ed by hybridization to 5RT were selected for sequencing.
Promoter constructs and transient transfections pGL3 luciferase reporter vectors used in this study include the promoter-less pGL3-basic vector and the pGL3-promoter vector, where luciferase is driven by the SV40 promoter (Promega). To generate the rat OCI-5 promoter-driven reporter vector p1410, an FspI fragment of pE5 (71410 to +162) was blunt-ligated into the SmaI site of the vector pGb (Leung and Miyamoto, 1989) , 5' UTR sequences (+49 to +162) were removed by Esp3 I/ SalI digestion and blunt ligation, and a KpnI/HindIII fragment encompassing nucleotides 71410 to +49 of the rat OCI-5 promoter was directly sublconed into the KpnI/ HindIII sites of pGL3-basic. Vectors p549, p199 and p46 are 5' deletion constructs generated by double digestion of p1410 with KpnI and StuI, BstXI or SmaI, respectively.
IEC-18 cells were transiently transfected by electroporation. Brie¯y, approximately 10 7 cells were washed in hepesbuered-saline (HBS), mixed with 8 mg DNA in 0.4 cm gap cuvettes in a ®nal volume of 100 ml HBS, and incubated on ice for 5 min before electroporation with a single pulse at 450 V, 125 mFd (BioRad Gene Pulser). Cuvettes were incubated at 378C for 10 min before plating onto 60 mm dishes in growth medium. Transient transfection of NRK-52E was performed with lipofectAMINE reagent (Gibco BRL) following conditions recommended by the manufacturer. In all cases pCMV-bgal was co-transfected as an internal control for transfection eciency. Luciferase and bgal assays were performed 48 h after transfection using the Luciferase Assay System (Promega).
